Oxidative stress, glucose metabolism, and the prevention of type 2 diabetes: pathophysiological insights.

With the rising epidemic of type 2 diabetes worldwide, including the United States, the death and disability due to the suboptimal control of cardiovascular disease associated with this epidemic has made prevention of type 2 diabetes emerge as a primary strategic intervention. Several modalities have been assessed in large randomized controlled trials for diabetes prevention such as lifestyle interventions and various pharmacologic agents. Included in these agents are metformin, thiazolidinediones, acarbose, angiotensin converting enzyme inhibitors, as well as angiotensin receptor blockers. Abrogation of oxidative stress appears to be a common soil hypothesis that explains the favorable effects of these agents on glucose metabolism, including the prevention of diabetes and its complications. This comprehensive review highlights the role of oxidative stress in the pathogenesis of diabetes, with emphasis on the major clinical trials conducted on prevention of type 2 diabetes.

[1]  D. Metodiewa,et al.  Reactive oxygen species and reactive nitrogen species: Relevance to cyto(neuro)toxic events and neurologic disorders. An overview , 1999, Neurotoxicity Research.

[2]  T. Kern,et al.  Nerve conduction and aldose reductase inhibition during 5 years of diabetes or galactosaemia in dogs , 1994, Diabetologia.

[3]  N. Ghosh,et al.  Antihyperglycemic effect of a new thiazolidinedione analogue and its role in ameliorating oxidative stress in alloxan-induced diabetic rats. , 2007, Life sciences.

[4]  L. Cai,et al.  Cell death and diabetic cardiomyopathy , 2007, Cardiovascular Toxicology.

[5]  Ye Xiong,et al.  Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress. , 2006, Free radical biology & medicine.

[6]  S. Yusuf,et al.  Effect of ramipril on the incidence of diabetes. , 2006, The New England journal of medicine.

[7]  M. Laakso,et al.  Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial , 2006, The Lancet.

[8]  J. Sowers,et al.  Myocardial myocyte remodeling and fibrosis in the cardiometabolic syndrome. , 2006, Journal of the cardiometabolic syndrome.

[9]  C. Roberts,et al.  Effect of a diet and exercise intervention on oxidative stress, inflammation and monocyte adhesion in diabetic men. , 2006, Diabetes research and clinical practice.

[10]  J. Tu,et al.  Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study , 2006, The Lancet.

[11]  J. Mehta,et al.  Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction. , 2006, The international journal of biochemistry & cell biology.

[12]  R. Simmons,et al.  Developmental origins of diabetes: the role of oxidative stress. , 2006, Free radical biology & medicine.

[13]  M. Valko,et al.  Free radicals, metals and antioxidants in oxidative stress-induced cancer. , 2006, Chemico-biological interactions.

[14]  A. Saiki,et al.  Probucol and atorvastatin decrease urinary 8-hydroxy-2'-deoxyguanosine in patients with diabetes and hypercholesterolemia. , 2006, Journal of atherosclerosis and thrombosis.

[15]  R. Steinbrook.  Facing the diabetes epidemic--mandatory reporting of glycosylated hemoglobin values in New York City. , 2006, The New England journal of medicine.

[16]  K. Griendling,et al.  Serial Review : The Role of Oxidative Stress in Diabetes mellitus Serial Review , 2006 .

[17]  J. Sowers,et al.  Introduction: organ involvement in the cardiometabolic syndrome. , 2006, Journal of the cardiometabolic syndrome.

[18]  T. Reinehr,et al.  The ‘accelerator hypothesis’: relationship between weight, height, body mass index and age at diagnosis in a large cohort of 9,248 German and Austrian children with type 1 diabetes mellitus , 2005, Diabetologia.

[19]  R. Nelson,et al.  Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress. , 2005, Diabetes.

[20]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.

[21]  J. Sowers,et al.  Renal Redox Stress and Remodeling in Metabolic Syndrome, Type 2 Diabetes mellitus, and Diabetic Nephropathy: Paying Homage to the Podocyte , 2005, American Journal of Nephrology.

[22]  Samy I McFarlane,et al.  Early insulin therapy and the risk of cardiovascular disease in Type 2 diabetes , 2005 .

[23]  J. Kornhuber,et al.  Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome , 2005, Journal of Neural Transmission.

[24]  Colin Mathers,et al.  The burden of mortality attributable to diabetes: realistic estimates for the year 2000. , 2005, Diabetes care.

[25]  B. Larijani,et al.  A review on the role of antioxidants in the management of diabetes and its complications. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[26]  I. Obrosova,et al.  Role for poly(ADP-ribose) polymerase activation in diabetic nephropathy, neuropathy and retinopathy. , 2005, Current vascular pharmacology.

[27]  E. Feldman,et al.  Short‐term hyperglycemia produces oxidative damage and apoptosis in neurons , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  G. Rutter,et al.  Metformin prevents glucose-induced protein kinase C-beta2 activation in human umbilical vein endothelial cells through an antioxidant mechanism. , 2005, Diabetes.

[29]  A. Aljada,et al.  Contemporary Reviews in Cardiovascular Medicine Metabolic Syndrome A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation , 2022 .

[30]  K. Kosaka,et al.  Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. , 2005, Diabetes research and clinical practice.

[31]  Lawrence A Leiter,et al.  Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition. , 2005, American journal of hypertension.

[32]  C. Roberts,et al.  Effects of exercise and diet on chronic disease. , 2005, Journal of applied physiology.

[33]  Xianglin Shi,et al.  Metal-induced oxidative stress and signal transduction. , 2004, Free radical biology & medicine.

[34]  Morihiro Matsuda,et al.  Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.

[35]  S. Moustafa.  Zinc might protect oxidative changes in the retina and pancreas at the early stage of diabetic rats. , 2004, Toxicology and applied pharmacology.

[36]  H. Endou,et al.  Oxidative stress and chronic allograft nephropathy. , 2004, Yonsei medical journal.

[37]  R. Kowluru,et al.  Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. , 2004, Diabetes.

[38]  R. Robertson.  Chronic Oxidative Stress as a Central Mechanism for Glucose Toxicity in Pancreatic Islet Beta Cells in Diabetes* , 2004, Journal of Biological Chemistry.

[39]  Philippe Giral,et al.  Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. , 2004, The Journal of clinical endocrinology and metabolism.

[40]  T. Meinertz,et al.  Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. , 2004, Free radical biology & medicine.

[41]  E. Feldman,et al.  Oxidative stress in the pathogenesis of diabetic neuropathy. , 2004, Endocrine reviews.

[42]  R. Jacob,et al.  Effects of HMG-CoA Reductase Inhibitors on Endothelial Function: Role of Microdomains and Oxidative Stress , 2004, Circulation.

[43]  T. Lehtimäki,et al.  Endothelial Dysfunction and Increased Arterial Intima-Media Thickness in Children With Type 1 Diabetes , 2004, Circulation.

[44]  Devjit Tripathy,et al.  Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-kappaB in mononuclear cells. , 2004, Metabolism: clinical and experimental.

[45]  Clive Osmond,et al.  Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. , 2004, The New England journal of medicine.

[46]  K. Petersen,et al.  Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. , 2004, The New England journal of medicine.

[47]  S. Saydah,et al.  Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. , 2004, JAMA.

[48]  Anthony Gamst,et al.  Association of the Metabolic Syndrome With History of Myocardial Infarction and Stroke in the Third National Health and Nutrition Examination Survey , 2004, Circulation.

[49]  E. Zarling,et al.  Evidence for increased lipid peroxidation in multiple sclerosis , 1992, Neurochemical Research.

[50]  K. Eriksson,et al.  Prevention of Type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise The 6-year Malmö feasibility study , 1991, Diabetologia.

[51]  W. Malaisse,et al.  The stimulus-secretion coupling of amino acid-induced insulin release , 1981, Diabetologia.

[52]  T. Kern,et al.  Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. , 2003, Free radical biology & medicine.

[53]  J. Mehta,et al.  Pioglitazone Inhibits LOX-1 Expression in Human Coronary Artery Endothelial Cells by Reducing Intracellular Superoxide Radical Generation , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[54]  Onofrio Resta,et al.  8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. , 2003, Chest.

[55]  I. G. Fantus,et al.  N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress. , 2003, American journal of physiology. Endocrinology and metabolism.

[56]  J. McArthur,et al.  New insights into diabetic polyneuropathy. , 2003, JAMA.

[57]  Qiong Guo,et al.  Separation and identification of DMPO adducts of oxygen-centered radicals formed from organic hydroperoxides by HPLC-ESR, ESI-MS and MS/MS , 2003, Journal of the American Society for Mass Spectrometry.

[58]  H. Utsumi,et al.  Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. , 2003, Journal of the American Society of Nephrology : JASN.

[59]  P. Clarkson,et al.  Oxidative stress, exercise, and antioxidant supplementation. , 2003, Toxicology.

[60]  Samy I McFarlane,et al.  Heart disease in diabetic patients , 2003, Current diabetes reports.

[61]  H. Takaishi,et al.  High glucose accelerates MCP-1 production via p38 MAPK in vascular endothelial cells. , 2003, Biochemical and biophysical research communications.

[62]  C. Kim,et al.  NAD(P)H oxidase participates in the signaling events in high glucose-induced proliferation of vascular smooth muscle cells. , 2003, Life sciences.

[63]  M. Vasson,et al.  An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress. , 2003, Metabolism: clinical and experimental.

[64]  John J. Shin,et al.  Prevention of type 2 diabetes , 2003, Current diabetes reports.

[65]  R. Freeman,et al.  Diabetic autonomic neuropathy. , 2003, Diabetes care.

[66]  Antonio Iradi,et al.  Antioxidant Activities and Oxidative Stress Byproducts in Human Hypertension , 2003, Hypertension.

[67]  D. Harrison,et al.  Electron Spin Resonance Characterization of Vascular Xanthine and NAD(P)H Oxidase Activity in Patients With Coronary Artery Disease: Relation to Endothelium-Dependent Vasodilation , 2003, Circulation.

[68]  M. Stevens,et al.  Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats. , 2003, Diabetes.

[69]  E. Benjamin,et al.  Obesity and Systemic Oxidative Stress: Clinical Correlates of Oxidative Stress in The Framingham Study , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[70]  E. Araki,et al.  Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic beta-cells. , 2003, Biochemical and biophysical research communications.

[71]  E. Feldman,et al.  Diabetic Peripheral and Autonomic Neuropathy , 2003 .

[72]  J. Holland,et al.  Endothelial NADPH oxidase: mechanism of activation by low-density lipoprotein. , 2003, Endothelium : journal of endothelial cell research.

[73]  Joseph L Evans,et al.  Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? , 2003, Diabetes.

[74]  P. Low,et al.  Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. , 2003, Diabetes.

[75]  Jukka T Salonen,et al.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.

[76]  Satoshi O. Suzuki,et al.  Impairment of mitochondrial DNA repair enzymes against accumulation of 8-oxo-guanine in the spinal motor neurons of amyotrophic lateral sclerosis , 2002, Acta Neuropathologica.

[77]  G. Deferrari,et al.  Taurine Prevents Apoptosis Induced by High Ambient Glucose in Human Tubule Renal Cells , 2002, Journal of Investigative Medicine.

[78]  H. Kasai,et al.  Switch to anaerobic glucose metabolism with NADH accumulation in the beta-cell model of mitochondrial diabetes. Characteristics of betaHC9 cells deficient in mitochondrial DNA transcription. , 2002, The Journal of biological chemistry.

[79]  J. Olzmann,et al.  High glucose‐induced oxidative stress and mitochondrial dysfunction in neurons , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[80]  S. Devaraj,et al.  α-Tocopherol Decreases Superoxide Anion Release in Human Monocytes Under Hyperglycemic Conditions Via Inhibition of Protein Kinase C-α , 2002 .

[81]  J. Tanus-Santos,et al.  Hypertension plus diabetes mimics the cardiomyopathy induced by nitric oxide inhibition in rats. , 2002, Chest.

[82]  Joseph L Evans,et al.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. , 2002, Endocrine reviews.

[83]  R. Robertson,et al.  A role for glutathione peroxidase in protecting pancreatic β cells against oxidative stress in a model of glucose toxicity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[84]  S. Olusi.  Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans , 2002, International Journal of Obesity.

[85]  P. Tsao,et al.  Impaired Nitric Oxide Synthase Pathway in Diabetes Mellitus: Role of Asymmetric Dimethylarginine and Dimethylarginine Dimethylaminohydrolase , 2002, Circulation.

[86]  S. Bonner-Weir,et al.  Involvement of c-Jun N-terminal Kinase in Oxidative Stress-mediated Suppression of Insulin Gene Expression* , 2002, The Journal of Biological Chemistry.

[87]  J. Morrow,et al.  Factors associated with oxidative stress in human populations. , 2002, American journal of epidemiology.

[88]  R. Brandes,et al.  Withdrawal of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Elicits Oxidative Stress and Induces Endothelial Dysfunction in Mice , 2002, Circulation research.

[89]  Samy I McFarlane,et al.  Metformin: An Update , 2002, Annals of Internal Medicine.

[90]  Z. Massy,et al.  Oxidative stress and chronic renal failure: markers and management. , 2002, Journal of nephrology.

[91]  V. Monnier,et al.  Alterations in renal mitochondrial respiration in response to the reactive oxoaldehyde methylglyoxal. , 2002, American journal of physiology. Renal physiology.

[92]  T. Hashimoto,et al.  Oxidative DNA Damage and Tubulointerstitial Injury in Diabetic Nephropathy , 2002, Nephron.

[93]  L. Cai,et al.  Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. , 2002, Diabetes.

[94]  Y. Hinokio,et al.  Urinary excretion of 8-oxo-7, 8-dihydro-2′-deoxyguanosine as a predictor of the development of diabetic nephropathy , 2002, Diabetologia.

[95]  H. Nawata,et al.  Accumulation of 8-hydroxy-2'-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats. , 2002, Diabetes.

[96]  H. Gavras,et al.  Angiotensin II as a cardiovascular risk factor , 2002, Journal of Human Hypertension.

[97]  K. Channon,et al.  Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus: Role of NAD(P)H Oxidase and Endothelial Nitric Oxide Synthase , 2002, Circulation.

[98]  C. Newgard,et al.  Mitochondrial Metabolism Sets the Maximal Limit of Fuel-stimulated Insulin Secretion in a Model Pancreatic Beta Cell , 2002, The Journal of Biological Chemistry.

[99]  R. Muniyappa,et al.  Pleiotropic Effects of Statins: Lipid Reduction and Beyond , 2002 .

[100]  H. von Gizycki,et al.  Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers. , 2002, Diabetes care.

[101]  J. Suzin,et al.  Evaluation of oxidative stress indices during treatment in pregnant women with intrauterine growth retardation. , 2002, Medical science monitor : international medical journal of experimental and clinical research.

[102]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[103]  S. Bonner-Weir,et al.  Involvement of Protein Kinase C β2 in c-mycInduction by High Glucose in Pancreatic β-Cells* , 2002, The Journal of Biological Chemistry.

[104]  R. Roman,et al.  Increased Renal Medullary Oxidative Stress Produces Hypertension , 2002, Hypertension.

[105]  M. Stumvoll,et al.  Glitazones: clinical effects and molecular mechanisms , 2002, Annals of medicine.

[106]  H. Trachtman,et al.  Chronic diabetic nephropathy: role of inducible nitric oxide synthase , 2002, Pediatric Nephrology.

[107]  M. Brownlee.  Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[108]  J. Díez,et al.  Oxidative Stress in Arterial Hypertension: Role of NAD(P)H Oxidase , 2001, Hypertension.

[109]  L. Aiello,et al.  Systemic considerations in the management of diabetic retinopathy. , 2001, American journal of ophthalmology.

[110]  C. Napoli,et al.  Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1. , 2001, European heart journal.

[111]  D. Green,et al.  The effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetes. , 2001, Journal of the American College of Cardiology.

[112]  S. Bonner-Weir,et al.  Activation of the Hexosamine Pathway Leads to Deterioration of Pancreatic β-Cell Function through the Induction of Oxidative Stress* , 2001, The Journal of Biological Chemistry.

[113]  L. Rodríguez-Mañas,et al.  High glucose induces cell death of cultured human aortic smooth muscle cells through the formation of hydrogen peroxide , 2001, British journal of pharmacology.

[114]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[115]  G. King,et al.  The role of oxidative stress in the onset and progression of diabetes and its complications: asummary of a Congress Series sponsored byUNESCO‐MCBN, the American Diabetes Association and the German Diabetes Society , 2001, Diabetes/metabolism research and reviews.

[116]  A. Schmidt,et al.  Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. , 2001, American journal of physiology. Endocrinology and metabolism.

[117]  M. S. Lee,et al.  Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. , 2001, Atherosclerosis.

[118]  Cheolju Lee,et al.  Protein Glycation , 2001, Annals of the New York Academy of Sciences.

[119]  L. Suzuki,et al.  Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels. , 2001, Diabetes.

[120]  A. Goldfine,et al.  Ascorbate Restores Endothelium-Dependent Vasodilation Impaired by Acute Hyperglycemia in Humans , 2001, Circulation.

[121]  U. Laufs,et al.  Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase. , 2001, Molecular pharmacology.

[122]  H. Drexler,et al.  Comparative Effect of ACE Inhibition and Angiotensin II Type 1 Receptor Antagonism on Bioavailability of Nitric Oxide in Patients With Coronary Artery Disease: Role of Superoxide Dismutase , 2001, Circulation.

[123]  M. Yen,et al.  Oxidized low density lipoprotein induces apoptosis via generation of reactive oxygen species in vascular smooth muscle cells. , 2001, Cardiovascular research.

[124]  C. Cooper,et al.  Nitric oxide synthases: structure, function and inhibition. , 2001, The Biochemical journal.

[125]  A. Aljada,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society The Suppressive Effect of Dietary Restriction and Weight Loss in the Obese on the Generation of Reactive Oxygen Species by Leukocytes, Lipid Per , 2022 .

[126]  H. Weinstein,et al.  A detailed interpretation of OH radical footprints in a TBP-DNA complex reveals the role of dynamics in the mechanism of sequence-specific binding. , 2000, Journal of molecular biology.

[127]  D. Harrison,et al.  Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. , 2000, Circulation research.

[128]  H. Utsumi,et al.  High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells. , 2000, Diabetes.

[129]  D. O'Connor,et al.  Plasma Hydrogen Peroxide Production in Human Essential Hypertension: Role of Heredity, Gender, and Ethnicity , 2000, Hypertension.

[130]  I. G. Fantus,et al.  Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[131]  D. Sorescu,et al.  Modulation of Protein Kinase Activity and Gene Expression by Reactive Oxygen Species and Their Role in Vascular Physiology and Pathophysiology , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[132]  N. Perkins.  The Rel/NF-κB family: friend and foe , 2000 .

[133]  S. Yusuf,et al.  Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction: Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry , 2000, Circulation.

[134]  Clive Osmond,et al.  The Fetal and Childhood Growth of Persons Who Develop Type 2 Diabetes , 2000, Annals of Internal Medicine.

[135]  I. Meredith,et al.  Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study. , 2000, Journal of the American College of Cardiology.

[136]  F. Cipollone,et al.  Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. , 2000, Diabetes.

[137]  R N Bergman,et al.  Carotid artery atherosclerosis in type-2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (The Insulin Resistance Atherosclerosis Study). , 2000, The American journal of cardiology.

[138]  S. Martín,et al.  Decreased endogenous antioxidant enzymatic status in essential hypertension , 2000, Journal of Human Hypertension.

[139]  Y. Kaneda,et al.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.

[140]  D. Giugliano,et al.  Hypertension and ascorbic acid , 2000, The Lancet.

[141]  C. Anderson,et al.  Predictors of death and vascular events in the elderly : the Perth Community Stroke Study. , 2000, Stroke.

[142]  D. Betteridge,et al.  What is oxidative stress? , 2000, Metabolism: clinical and experimental.

[143]  S. Yusuf,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[144]  T. Chiba,et al.  Beneficial effects of nitric oxide synthase inhibition on the recovery of neurological function after spinal cord injury in rats , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[145]  H. Thompson,et al.  Effect of increased vegetable and fruit consumption on markers of oxidative cellular damage. , 1999, Carcinogenesis.

[146]  C. Chiueh,et al.  Neuroprotective Properties of Nitric Oxide , 1999, Annals of the New York Academy of Sciences.

[147]  C. Hubel,et al.  Oxidative Stress in the Pathogenesis of Preeclampsia (44447) , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[148]  G. Assmann,et al.  Coronary heart disease: reducing the risk: a worldwide view. International Task Force for the Prevention of Coronary Heart Disease. , 1999, Circulation.

[149]  M. Ferencik,et al.  Chemistry, physiology and pathology of free radicals. , 1999, Life sciences.

[150]  A. Windebank,et al.  Neurons Undergo Apoptosis in Animal and Cell Culture Models of Diabetes , 1999, Neurobiology of Disease.

[151]  C. Wollheim,et al.  Hydrogen Peroxide Alters Mitochondrial Activation and Insulin Secretion in Pancreatic Beta Cells* , 1999, The Journal of Biological Chemistry.

[152]  C. Cotman,et al.  Bcl-2 Facilitates Recovery from DNA Damage after Oxidative Stress , 1999, Experimental Neurology.

[153]  B. Kahn,et al.  Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus. , 1999, The New England journal of medicine.

[154]  A. Folsom,et al.  Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. , 1999, Diabetes care.

[155]  M. Zámocký,et al.  Understanding the structure and function of catalases: clues from molecular evolution and in vitro mutagenesis. , 1999, Progress in biophysics and molecular biology.

[156]  H. Makino,et al.  Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-α and inducible nitric oxide synthase in diabetic rat glomeruli , 1999, Diabetologia.

[157]  R. Munday,et al.  Protection against the co-operative toxicity of nitric oxide and oxygen free radicals by overexpression of antioxidant enzymes in bioengineered insulin-producing RINm5F cells , 1999, Diabetologia.

[158]  A. Dominiczak,et al.  Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. , 1999, Hypertension.

[159]  S. Bonner-Weir,et al.  Chronic Hyperglycemia Triggers Loss of Pancreatic β Cell Differentiation in an Animal Model of Diabetes* , 1999, The Journal of Biological Chemistry.

[160]  M. Laakso,et al.  Hyperglycemia and cardiovascular disease in type 2 diabetes. , 1999, Diabetes.

[161]  D. Ingber,et al.  How cells (might) sense microgravity , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[162]  E. Cerasi,et al.  Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. , 1999, Diabetes.

[163]  S. Genuth,et al.  Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Contro , 1999, Diabetes.

[164]  T. Miyata,et al.  Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions. , 1999, Journal of the American Society of Nephrology : JASN.

[165]  B. Ames,et al.  Endogenous oxidative damage of mtDNA. , 1999, Mutation research.

[166]  A. Sasaki,et al.  [Prevention of diabetes mellitus]. , 1999, Nihon rinsho. Japanese journal of clinical medicine.

[167]  J. Trojanowski,et al.  Oxidation of Cytosolic Proteins and Expression of Creatine Kinase BB in Frontal Lobe in Different Neurodegenerative Disorders , 1999, Dementia and Geriatric Cognitive Disorders.

[168]  A. Lee,et al.  Contributions of polyol pathway to oxidative stress in diabetic cataract , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[169]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[170]  G. Dianov,et al.  Oxidative DNA damage processing in nuclear and mitochondrial DNA. , 1999, Biochimie.

[171]  J. Knight.  Free radicals: their history and current status in aging and disease. , 1998, Annals of clinical and laboratory science.

[172]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[173]  S. Schiekofer,et al.  Insufficient Glycemic Control Increases Nuclear Factor-κB Binding Activity in Peripheral Blood Mononuclear Cells Isolated From Patients With Type 1 Diabetes , 1998, Diabetes Care.

[174]  M. Laakso,et al.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. , 1998, The New England journal of medicine.

[175]  M. Degli Esposti,et al.  Mitochondria and cells produce reactive oxygen species in virtual anaerobiosis: relevance to ceramide‐induced apoptosis , 1998, FEBS letters.

[176]  G. Pieper,et al.  Oral administration of the antioxidant, N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction. , 1998, Journal of cardiovascular pharmacology.

[177]  R. Bucala,et al.  Advanced glycation end products increase retinal vascular endothelial growth factor expression. , 1998, The Journal of clinical investigation.

[178]  V. Salomaa,et al.  Impact of Diabetes on Mortality After the First Myocardial Infarction , 1998, Diabetes Care.

[179]  L. Aiello,et al.  Diabetic Retinopathy , 1998, Diabetes Care.

[180]  Christopher K. Glass,et al.  The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation , 1998, Nature.

[181]  G. King,et al.  Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus , 1997, Journal of Molecular Medicine.

[182]  Z. Naito,et al.  Immunohistochemical and morphometric evaluations of coronary atherosclerotic plaques associated with myocardial infarction and diabetes mellitus. , 1998, Journal of atherosclerosis and thrombosis.

[183]  S. Doctrow,et al.  Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: a key role for reactive oxygen species in ischemic brain injury. , 1998, The Journal of pharmacology and experimental therapeutics.

[184]  A. Manto,et al.  Defective Plasma Antioxidant Defenses and Enhanced Susceptibility to Lipid Peroxidation in Uncomplicated IDDM , 1997, Diabetes.

[185]  J. D. Porter,et al.  Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy , 1997, Neuromuscular Disorders.

[186]  J. Witztum,et al.  Excess iron induces hepatic oxidative stress and transforming growth factor β1 in genetic hemochromatosis , 1997, Hepatology.

[187]  M. Prentki,et al.  Metabolic Fate of Glucose in Purified Islet Cells , 1997, The Journal of Biological Chemistry.

[188]  Ronald Klein,et al.  Diabetic eye disease , 1997, The Lancet.

[189]  T. Ozawa,et al.  Fragile mitochondrial DNA: the missing link in the apoptotic neuronal cell death in Parkinson's disease. , 1997, Biochemical and biophysical research communications.

[190]  L. Packer,et al.  Gliclazide scavenges hydroxyl, superoxide and nitric oxide radicals: an ESR study. , 1997, Research communications in molecular pathology and pharmacology.

[191]  N. Cairns,et al.  An Assessment of Oxidative Damage to Proteins, Lipids, and DNA in Brain from Patients with Alzheimer's Disease , 1997, Journal of neurochemistry.

[192]  S. Lenzen,et al.  Relation Between Antioxidant Enzyme Gene Expression and Antioxidative Defense Status of Insulin-Producing Cells , 1997, Diabetes.

[193]  B. Howard,et al.  Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.

[194]  U. Das,et al.  Oxidant stress, anti-oxidants and essential fatty acids in systemic lupus erythematosus. , 1997, Prostaglandins, leukotrienes, and essential fatty acids.

[195]  H. Ochi,et al.  Quantitative immunohistochemical determination of 8-hydroxy-2'-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[196]  H. Gin,et al.  Short-Term Insulin Therapy and Normoglycemia: Effects on erythrocyte lipid peroxidation in NIDDM patients , 1997, Diabetes Care.

[197]  E. Schleicher,et al.  Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. , 1997, The Journal of clinical investigation.

[198]  L. Olson,et al.  Differentiation of glucose toxicity from beta cell exhaustion during the evolution of defective insulin gene expression in the pancreatic islet cell line, HIT-T15. , 1997, The Journal of clinical investigation.

[199]  G. Reaven.  Banting lecture 1988 , 1997 .

[200]  J. Knight.  Reactive oxygen species and the neurodegenerative disorders. , 1997, Annals of clinical and laboratory science.

[201]  N. Traverso,et al.  Good glycaemic control reduces oxidation and glycation end-products in collagen of diabetic rats , 1996, Diabetologia.

[202]  J. O'connor,et al.  Aging of the liver: Age‐associated mitochondrial damage in intact hepatocytes , 1996, Hepatology.

[203]  A. Erwin,et al.  Glucose-dependent formation of free radical species in lens homogenate. , 1996, Biochemical and molecular medicine.

[204]  E. Voest,et al.  Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. , 1996, The Journal of clinical investigation.

[205]  H. Hammes,et al.  Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[206]  T. Kern,et al.  Abnormalities of Retinal Metabolism in Diabetes or Experimental Galactosemia. III. Effects of Antioxidants , 1996, Diabetes.

[207]  Jacqueline K. Barton,et al.  Oxidative DNA damage through long-range electron transfer , 1996, Nature.

[208]  N. Chandel,et al.  Molecular Oxygen Modulates Cytochrome c Oxidase Function* , 1996, The Journal of Biological Chemistry.

[209]  M. Fink,et al.  ROLE OF OXIDANT STRESS IN THE ADULT RESPIRATORY DISTRESS SYNDROME: EVALUATION OF A NOVEL ANTIOXIDANT STRATEGY IN A PORCINE MODEL OF ENDOTOXIN‐INDUCED ACUTE LUNG INJURY , 1996, Shock.

[210]  M. Creager,et al.  -.____----.---_-Impaired Nitric Oxide-Mediated Vasodilation in Patients With Non-Insulin-Dependent Diabetes Mellitw , 2016 .

[211]  J. H. Johnson,et al.  Activation of stimulus-secretion coupling in pancreatic beta-cells by specific products of glucose metabolism. Evidence for privileged signaling by glycolysis. , 1996, The Journal of biological chemistry.

[212]  G. Paolisso,et al.  Oxidative Stress and Diabetic Vascular Complications , 1996, Diabetes Care.

[213]  S. Lenzen,et al.  Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. , 1996, Free radical biology & medicine.

[214]  Farris K. Timimi,et al.  Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. , 1996, The Journal of clinical investigation.

[215]  I. Chiappino,et al.  Oxidative damage in human liver transplantation. , 1995, Free radical biology & medicine.

[216]  Takaaki Kobayashi,et al.  Superoxide scavenging activity in experimental liver transplantation , 1995, Transplant international : official journal of the European Society for Organ Transplantation.

[217]  J. Nyengaard,et al.  Elevated glucose levels increase retinal glycolysis and sorbitol pathway metabolism. Implications for diabetic retinopathy. , 1995, Investigative ophthalmology & visual science.

[218]  G. Paolisso,et al.  Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects. , 1995, The American journal of physiology.

[219]  J. Nyengaard,et al.  Inhibition of Sorbitol Dehydrogenase: Effects on Vascular and Neural Dysfunction in Streptozocin-Induced Diabetic Rats , 1995, Diabetes.

[220]  J. Simoneau,et al.  Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[221]  S. Shah,et al.  The role of reactive oxygen metabolites in glomerular disease. , 1995, Annual review of physiology.

[222]  C. Newgard,et al.  Metabolic coupling factors in pancreatic beta-cell signal transduction. , 1995, Annual review of biochemistry.

[223]  L. Aiello,et al.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.

[224]  Joan W. Miller,et al.  Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. , 1994, American journal of ophthalmology.

[225]  B. Halliwell,et al.  Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? , 1994, The Lancet.

[226]  Joan W. Miller,et al.  Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. , 1994, The American journal of pathology.

[227]  A. Schmidt,et al.  Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[228]  H. Ischiropoulos,et al.  Oxidative chemistry of peroxynitrite. , 1994, Methods in enzymology.

[229]  I. Fridovich,et al.  The role of O2.- in the production of HO.: in vitro and in vivo. , 1994, Free radical biology & medicine.

[230]  B. Wallaert,et al.  Oxidative inactivation of alpha 1-proteinase inhibitor by alveolar epithelial type II cells. , 1993, Journal of applied physiology.

[231]  A. McElduff,et al.  Diabetes Control and Complications Trial , 1993 .

[232]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[233]  J. McCord,et al.  Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[234]  D. Nathan,et al.  Long-term complications of diabetes mellitus. , 1993, The New England journal of medicine.

[235]  J. Nyengaard,et al.  Hyperglycemic Pseudohypoxia and Diabetic Complications , 1993, Diabetes.

[236]  Desmond O'Neill,et al.  The ageing process , 1993 .

[237]  B. Halliwell,et al.  DNA and free radicals , 1993 .

[238]  U. Das,et al.  Are free radicals involved in the pathobiology of human essential hypertension? , 1993, Free radical research communications.

[239]  S. Wolff.  Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. , 1993, British medical bulletin.

[240]  M. Brownlee,et al.  Glycation Products and the Pathogenesis of Diabetic Complications , 1992, Diabetes Care.

[241]  E. Feldman,et al.  Complications: Neuropathy, Pathogenetic Considerations , 1992, Diabetes Care.

[242]  J. Morrow,et al.  Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation. , 1992, The Journal of clinical investigation.

[243]  G. R. Davies,et al.  Mucosal reactive oxygen metabolite production in duodenal ulcer disease. , 1992, Gut.

[244]  S. Wolff,et al.  Formation of hydrogen peroxide by lens proteins: protein-derived hydrogen peroxide as a potential mechanism of oxidative insult to the lens. , 1992, Free radical biology & medicine.

[245]  D. Armstrong,et al.  Relationship of lipid peroxides to diabetic complications. Comparison with conventional laboratory tests. , 1992, Journal of diabetes and its complications.

[246]  J. Herlitz,et al.  Prognosis in diabetics with chest pain or other symptoms suggestive of acute myocardial infarction. , 1992, Cardiology.

[247]  R. Bucala,et al.  Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. , 1992, Advances in pharmacology.

[248]  J. Sasaki,et al.  Does superoxide underlie the pathogenesis of hypertension? , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[249]  P. Abrescia,et al.  Relative ratios of lactoferrin, albumin, and acid phosphatase seminal levels as sperm quality markers in fertile and infertile men. , 1991, Journal of andrology.

[250]  J. Baynes.  Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.

[251]  E. Stadtman,et al.  Metal-catalyzed oxidation of proteins. Physiological consequences. , 1991, The Journal of biological chemistry.

[252]  P. Cerutti,et al.  Oxidant stress and carcinogenesis , 1991, European journal of clinical investigation.

[253]  J. McCord,et al.  Interstitial equilibration of superoxide dismutase correlates with its protective effect in the isolated rabbit heart. , 1991, Journal of molecular and cellular cardiology.

[254]  W. Pryor,et al.  Aldehydes, hydrogen peroxide, and organic radicals as mediators of ozone toxicity. , 1991, Free radical biology & medicine.

[255]  F. Fein.  Diabetic Cardiomyopathy , 1990, Diabetes Care.

[256]  T. Lüscher,et al.  Impaired endothelium-dependent relaxations in hypertensive resistance arteries involve cyclooxygenase pathway. , 1990, The American journal of physiology.

[257]  A. Vaille,et al.  Anti-inflammatory activity of various superoxide dismutases on polyarthritis in the Lewis rat. , 1990, Biochemical pharmacology.

[258]  P. Ward,et al.  Role of O2- in neutrophil recruitment into sites of dermal and pulmonary vasculitis. , 1990, Free radical biology & medicine.

[259]  D. Janero,et al.  Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. , 1990, Free radical biology & medicine.

[260]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[261]  P. Lacy,et al.  Oxygen Free-Radical Scavengers and Immune Destruction of Murine Islets in Allograft Rejection and Multiple Low-Dose Streptozocin-Induced Insulitis , 1989, Diabetes.

[262]  P. Wilson,et al.  The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study. , 1988, JAMA.

[263]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[264]  M. Lou,et al.  Glutathione depletion in the lens of galactosemic and diabetic rats. , 1988, Experimental eye research.

[265]  D. Harman,et al.  The aging process. , 1981, Basic life sciences.

[266]  L. Oberley.  Free radicals and diabetes. , 1988, Free radical biology & medicine.

[267]  S P Wolff,et al.  Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. , 1987, The Biochemical journal.

[268]  D L DeMets,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. VI. Retinal photocoagulation. , 1987, Ophthalmology.

[269]  H. Cheng,et al.  The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis. , 1986, Metabolism: clinical and experimental.

[270]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[271]  S. Lenzen,et al.  Regulation of insulin secretion by energy metabolism in pancreatic B-cell mitochondria. Studies with a non-metabolizable leucine analogue. , 1984, The Biochemical journal.

[272]  B. Halliwell,et al.  Oxygen toxicity, oxygen radicals, transition metals and disease. , 1984, The Biochemical journal.

[273]  T. Kern,et al.  Experimental Galactosemia Produces Diabetic-like Retinopathy , 1984, Diabetes.

[274]  G. Cohen.  Oxy-radical toxicity in catecholamine neurons. , 1984, Neurotoxicology.

[275]  R. Barnard,et al.  Long-Term Use of a High-Complex-Carbohydrate, High-Fiber, Low-Fat Diet and Exercise in the Treatment of NIDDM Patients , 1983, Diabetes Care.

[276]  P. Mclean,et al.  The Effect of an Aldose Reductase Inhibitor (Sorbinil) on the Level of Metabolites in Lenses of Diabetic Rats , 1983, Diabetes.

[277]  W. Malaisse.  Alloxan toxicity to the pancreatic B-cell. A new hypothesis. , 1982, Biochemical pharmacology.

[278]  S. Hamilton,et al.  Ischemic injury in the cat small intestine: Role of superoxide radicals , 1982 .

[279]  P. Higgins,et al.  Reaction of monosaccharides with proteins: possible evolutionary significance. , 1981, Science.

[280]  W. Malaisse,et al.  The Stimulus-secretion Coupling of Amino Acid-induced Insulin Release: Metabolism and Cationic Effects of Leucine , 1980, Diabetes.

[281]  Daniel L. McGee,et al.  Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.

[282]  N. Hotta,et al.  Lipid peroxide level in plasma of diabetic patients. , 1979, Biochemical medicine.

[283]  W. Kannel,et al.  Obesity and cardiovascular disease: The Framingham study , 1976 .

[284]  J. Gutteridge,et al.  The inhibition of lipid autoxidation by human serum and its relation to serum proteins and alpha-tocopherol. , 1974, Clinical science and molecular medicine.

[285]  V. Kagan,et al.  Light-induced free radical oxidation of membrane lipids in photoreceptors of frog retina. , 1973, Biochimica et Biophysica Acta.

[286]  A. Grishman,et al.  New type of cardiomyopathy associated with diabetic glomerulosclerosis. , 1972, The American journal of cardiology.

[287]  D. Harman.  Aging: a theory based on free radical and radiation chemistry. , 1956, Journal of gerontology.

[288]  J. Clemmesen,et al.  Studies on the role of lipoperoxides in human pathology. II. The presence of peroxidized lipids in the atherosclerotic aorta. , 2009, Acta pathologica et microbiologica Scandinavica.

[289]  R. Fitz.  The Prevention of Diabetes Mellitus , 1940 .

[290]  M. Gomberg,et al.  AN INSTANCE OF TRIVALENT CARBON: TRIPHENYLMETHYL. , 1900 .

[291]  F. R. Japp,et al.  LXXII.—Preparation of 2′ : 3′-diphenylindoles from benzoïn and primary benzenoid amines , 1894 .

[292]  H. Fenton,et al.  LXXIII.—Oxidation of tartaric acid in presence of iron , 1894 .